Coronavirus BRIEFING
Supported by Essilor

Crisis Response Tactics

For Some MDs, Long COVID Burnout Is a New Reality

By Staff
Monday, April 8, 2024 8:02 AM Dhaval Desai, MD, was teaching his 4-year-old to ride a bike after another exhausting shift at the hospital during the summer after the first COVID-19 surge. He was putting on a happy face and forcing out a "Yay!" he did not feel. The pandemic had taken its toll, and he just wanted to lie down and be alone. Realizing that he was "scraping to find joy" was when he knew something was wrong.

Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief

By Staff
Monday, April 8, 2024 8:02 AM Paxlovid does not significantly alleviate symptoms of COVID-19 compared with placebo among nonhospitalized adults, a new study published on April 3 in The New England Journal of Medicine found.

How Therapy Can Help During Life-Changing Events Like COVID

By Staff
Thursday, April 4, 2024 7:59 AM When the COVID-19 pandemic hit 4 years ago, Jenn Kearney felt extra thankful for her years of therapy. The 34-year-old digital communications manager from Boston said her 11 years of doing therapy, specifically cognitive behavioral therapy, or CBT, prior to the pandemic had given her skills and “ways to cope and adapt that not only benefited me, but the people around me,” she said.

Paxlovid Fails to Shorten COVID in Standard-Risk and Vaccinated At-Risk Patients

By Staff
Thursday, April 4, 2024 6:09 AM Nirmatrelvir/ritonavir (Paxlovid) failed to shorten COVID-19 symptom duration among people at standard risk for severe COVID-19 and among vaccinated people with at least one risk factor for severe disease, according to final results of the phase II/III EPIC-SR.

Latest COVID Vax Cuts Hospitalization Risk in Immunocompromised People

By Staff
Tuesday, April 2, 2024 6:12 AM For adults who are immunocompromised, the updated 2023-2024 COVID-19 vaccine reduced risk of hospitalization compared with not getting the shot, according to CDC data.

Pediatric Mental Health Was Stable Early in the Pandemic

By Staff
Friday, March 29, 2024 8:02 AM The mental health of children and adolescents was largely stable during the first year of the COVID-19 pandemic, but racial disparities in access to outpatient psychiatric care worsened, new research suggested.

Fauci: When Confronted With Misinformation, Stick to the Science

By Staff
Friday, March 29, 2024 6:15 AM While public health professionals don't get formal training on how to operate in highly politically charged and divisive environments, the best thing to do is stick to the facts, evidence, and data, Anthony Fauci, MD, former director of the National Institute of Allergy and Infectious Diseases (NIAID), told an audience of health policy graduate students on Wednesday.

New Data: Long COVID Cases Surge

By Staff
Thursday, March 28, 2024 8:02 AM Experts worry a recent rise in long COVID cases—fueled by a spike in winter holiday infections and a decline in masking and other measures—could continue into this year.

Health Workers Fear Profits May Trump Safety in New CDC Recommendations

By Staff
Wednesday, March 27, 2024 8:02 AM Four years after hospitals in New York City overflowed with COVID-19 patients, emergency physician Sonya Stokes remains shaken by how unprepared and misguided the American health system was.

How COVID-19 Treatments Affect Patients With IBD

By Staff
Tuesday, March 26, 2024 8:02 AM Inflammatory bowel disease (IBD) therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not escalate IBD flares, with prior vaccination for COVID-19 helping reduce complications from the virus.

Medscape Placeholder

By Staff
Monday, March 25, 2024 8:02 AM

Severe Flu Confers Higher Risk for Neuro Disorders vs COVID

By Staff
Monday, March 25, 2024 8:02 AM Hospitalization for influenza is linked to a greater risk for subsequent neurologic disorders including migraine, stroke, or epilepsy than hospitalization for COVID-19, results of a large study show.

New Monoclonal Authorized to Prevent COVID in Immunocompromised People

By Staff
Monday, March 25, 2024 6:09 AM The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune response following vaccination, the agency announced on Friday.

U.S. Life Expectancy Increasing, but So Is Child Death Rate

By Staff
Friday, March 22, 2024 7:59 AM The risk of death due to COVID-19 has declined so much that life expectancy in the U.S. is once again on the rise.

COVID Vaccination Protects Against Infection-Related Risks for Stillbirth and Preterm Birth

By Staff
Thursday, March 21, 2024 8:02 AM Previous research has established that there is an increased risk for stillbirth and preterm birth after SARS-CoV-2 infection in pregnancy. A new study finds that the timing of infection during pregnancy matters, with early infection being a worse risk factor than late infection for the two outcomes.